查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1802997

2032 年微生物友善活性成分市场预测：按成分类型、形式、技术、分销管道、应用、最终用户和地区进行的全球分析

Microbiome-Friendly Actives Market Forecasts to 2032 - Global Analysis By Ingredient Type, Form, Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

据 Stratistics MRC 称，全球微生物组友善活性成分市场预计在 2025 年达到 3.116 亿美元，到 2032 年将达到 15.973 亿美元，预测期内的复合年增长率为 26.3%。微生物组友善活性成分是专门配製的生物活性成分，用于支持、保护和平衡人体皮肤和肠道细菌——维持健康的有益微生物的复杂生态系统。这些活性成分透过促进有益细菌的生长、抑制有害微生物和维持天然微生物多样性来发挥作用，这对屏障功能、免疫力和整体健康至关重要。与可能破坏微生物平衡的传统化学物质不同，微生物组友善活性成分温和且具针对性，通常来自益生元、益生菌和后生元。它们的应用涵盖护肤、个人护理和营养，反映出消费者对安全有效地培育天然微生物健康的产品的需求日益增长。

个人化护肤需求日益增长

个人化护肤需求的日益增长，对微生物友善活性成分市场产生了强烈而积极的影响。消费者越来越寻求符合自身独特皮肤微生物组的客製化解决方案，这推动了创新和产品多样化。这一趋势促使护肤品牌开发针对特定需求（例如敏感性肌肤、痤疮和老龄化，同时保持微生物组的平衡。随着人们对微生物组健康的认识不断提高，个人化方法正在提升消费者的信任度和满意度，从而刺激市场采用，并加速整个产业的成长机会。

研发和配方成本高

由于研发和配方成本高昂，微生物友善活性成分市场面临巨大限制，阻碍了快速创新和产品开发。高成本增加了中小企业的进入门槛，并限制了它们有效扩展解决方案的能力。因此，市场扩张可能会放缓，价格可能维持高位，消费者和製造商的采用可能会受到抑制，最终阻碍该行业的整体成长轨迹。

清洁美容与益生菌/益生元趋势

清洁美容和益生菌/益生元趋势的日益流行正在积极推动市场发展。清洁美容强调透明度、永续性，并避免使用刺激性化学物质，而益生菌和益生元的创新则有助于维持皮肤微生物群的平衡，从而提升产品的可信度和需求。这种协同效应鼓励品牌将有益于微生物群的活性成分融入护肤方案中，从而推动创新、消费者信任和采用，最终推动市场持续扩张。

监管模糊性

由于监管不明确，微生物组友善活性成分市场面临负面影响和阻碍因素，这导致产品核可、安全标准和标籤要求等方面的不确定性。企业难以协调不同地区不一致的指导方针，导致产品发布延迟并增加合规成本。这种不确定性可能会抑制研发和创新投资，减缓市场扩张，限制消费者接受度，并最终限制以微生物组为重点的医疗保健和个人护理行业的整体成长潜力。

COVID-19的影响

新冠疫情以多种方式影响了微生物友善活性成分市场。最初，供应链中断、生产放缓以及消费者支出减少阻碍了成长。然而，这场危机提高了人们对免疫健康、肠道健康和个人健康的认识，推动了对基于微生物组的护肤和营养产品的长期需求。消费者越来越寻求天然、安全且有科学依据的解决方案，儘管疫情期间存在短期挑战，但微生物友善活性成分仍被视为一个具有韧性且前景广阔的类别。

预测期内，合益素市场预计将成为最大的市场

预计合益素领域将在预测期内占据最大的市场占有率，这得益于益生元和益生菌的靶向融合，形成协同配方，从而增强肠道-皮肤和肠道-脑轴的功能。这种融合，加上消费者对整体和生物活性解决方案日益增长的需求，正在推动功能性护肤、可食用产品和健康产品的创新。合益素还能实现精准的微生物组调控，增强监管信心并获得科学检验。因此，合益素正在重塑产品开发平臺，并加速其在美容、营养保健品和治疗领域的应用。

预计血清部分在预测期内将出现最高的复合年增长率。

预计精华液细分市场将在预测期内达到最高成长率。受消费者对简约高效配方日益增长的需求推动，精华液为整合后生元和发酵萃取物等微生物平衡成分提供了一种理想的形式。其轻盈的质地和精准的靶向性提高了成分的生物生物有效性，促进了活性成分封装和协同增效配方的创新。这种融合正在推动优质化，拓展药妆应用，并将微生物友善活性成分定位为下一代皮肤健康的重要支柱。

占比最大的地区：

在预测期内，亚太地区预计将占据最大的市场占有率，这得益于消费者对整体健康和科学配方日益增长的需求。人们对肠道-皮肤-大脑之间连结的认识日益加深，促使各大品牌在食品、个人护理和补充剂领域不断创新，以促进微生物平衡。受人口老化和积极主动的健康策略推动，日本和东南亚在微生物组友善活性成分的应用方面处于领先地位。该地区的监管变化和研发投入进一步推动了成长，将微生物友善活性成分定位为预防性医疗保健和消费者信任的变革力量。

复合年增长率最高的地区：

预计北美将在预测期内实现最高的复合年增长率，这得益于消费者对肠道和皮肤健康的日益关注、对天然和洁净标示产品的需求以及个性化护肤行业的兴起。该地区先进的研发生态系统、领先的化妆品和营养保健品牌的涌现，以及强化的安全性和功效监管，将进一步加速市场应用。生物技术创新投资的不断增加以及消费者对益生菌和益生元活性成分的偏好，正在推动其稳定成长。

免费客製化服务：

此报告的订阅者可以从以下免费自订选项中选择一项：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球微生物友善活性成分市场（依成分类型）

  • 益生元
  • 益生菌
  • 后生元
  • 合益素
  • 植物萃取物
  • 胜肽
  • 维生素和矿物质

6. 全球微生物友善活性成分市场（依形式）

  • 胶囊和片剂
  • 粉末
  • 液体
  • 软糖
  • 乳霜和乳液
  • 美容精华液
  • 油

7. 全球微生物友善活性成分市场（按技术）

  • 基于基因体学的活性成分
  • 代谢体学衍生化合物
  • 人工智慧驱动的个人化微生物组处方
  • 封装和递送系统

8. 全球微生物友善活性成分市场（依通路）

  • 大卖场/超级市场
  • 专卖店
  • 药局
  • 网路零售
  • 皮肤科诊所

9. 全球微生物友善活性成分市场（按应用）

  • 护肤
  • 护髮
  • 口腔清洁用品
  • 女性卫生
  • 婴儿护理
  • 伤口癒合
  • 抗衰老和屏障修復

第 10 章。全球微生物组友善活性成分市场（按最终用户）

  • 成人
  • 孩子
  • 老年人
  • 宠物和牲畜

11. 全球微生物友善活性成分市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：企业概况

  • Chr. Hansen Holding A/S
  • DuPont
  • Lonza Group AG
  • Yakult Honsha Co., Ltd.
  • Lesaffre Group
  • Nestle Health Science
  • Danone SA
  • Evonik Industries AG
  • BioGaia AB
  • DSM-Firmenich AG
  • Probi AB
  • SynbioTech Inc.
  • Kerry Group plc
  • Novozymes A/S
  • Herbalife Nutrition Ltd.
  • Arla Foods Ingredients Group
  • Sabinsa Corporation
  • Morinaga Milk Industry Co., Ltd.
Product Code: SMRC30523

According to Stratistics MRC, the Global Microbiome-Friendly Actives Market is accounted for $311.6 million in 2025 and is expected to reach $1,597.3 million by 2032 growing at a CAGR of 26.3% during the forecast period. Microbiome-Friendly Actives are bioactive ingredients specifically formulated to support, protect, and balance the human skin or gut microbiome-the complex ecosystem of beneficial microorganisms that maintain health. These actives work by promoting the growth of beneficial bacteria, inhibiting harmful microbes, and preserving the natural microbial diversity essential for barrier function, immunity, and overall wellbeing. Unlike traditional chemicals that may disrupt microbial balance, microbiome-friendly actives are gentle, targeted, and often derived from prebiotics, probiotics, or postbiotics. Their application spans skincare, personal care, and nutrition, reflecting a growing consumer demand for products that nurture natural microbial health safely and effectively.

Market Dynamics:

Driver:

Rising demand for personalized skincare

The rising demand for personalized skincare is creating a strong and positive impact on the Microbiome-Friendly Actives Market. Consumers are increasingly seeking tailored solutions that align with their unique skin microbiome, driving innovation and product diversification. This trend encourages skincare brands to develop formulations that target specific needs such as sensitivity, acne, or aging, while preserving microbiome balance. As awareness about microbiome health grows, personalized approaches enhance customer trust and satisfaction, fueling market adoption and accelerating growth opportunities across the sector.

Restraint:

High R&D and formulation costs

The Microbiome-Friendly Actives Market faces a notable constraint due to high R&D and formulation costs, which hinder rapid innovation and product development. These elevated expenses increase entry barriers for smaller companies and limit the ability to scale solutions efficiently. As a result, market expansion is slowed, pricing remains elevated, and adoption by consumers and manufacturers may be restrained, ultimately impeding the sector's overall growth trajectory.

Opportunity:

Clean beauty and probiotic/prebiotic trends

The growing popularity of clean beauty and probiotic/prebiotic trends is positively driving the market, as consumers increasingly seek products that promote skin health through natural, safe, and effective formulations. Clean beauty emphasizes transparency, sustainability, and avoidance of harsh chemicals, while probiotic and prebiotic innovations support balanced skin microbiota, boosting product credibility and demand. This synergy encourages brands to integrate microbiome-friendly actives into skincare solutions, fostering innovation, consumer trust, and widespread adoption, ultimately fueling sustained market expansion.

Threat:

Regulatory ambiguity

The Microbiome-Friendly Actives Market faces a negative and hindering impact due to regulatory ambiguity, which creates uncertainty around product approvals, safety standards, and labeling requirements. Companies struggle to navigate inconsistent guidelines across regions, delaying product launches and increasing compliance costs. This uncertainty discourages investment in research and innovation, slows market expansion, and may result in limited consumer adoption, ultimately constraining the overall growth potential of the microbiome-focused health and personal care sector.

Covid-19 Impact

The Covid-19 pandemic had a mixed impact on the Microbiome-Friendly Actives Market. Initially, disruptions in supply chains, manufacturing slowdowns, and reduced consumer spending hindered growth. However, the crisis heightened awareness of immune health, gut health, and personal wellness, driving long-term demand for microbiome-based skincare and nutritional products. Consumers increasingly sought natural, safe, and science-backed solutions, positioning microbiome-friendly actives as a resilient and promising category despite short-term challenges during the pandemic.

The synbiotics segment is expected to be the largest during the forecast period

The synbiotics segment is expected to account for the largest market share during the forecast period, because of merging targeted prebiotics and probiotics into synergistic formulations that enhance gut-skin and gut-brain axes. This convergence is driving innovation in functional skincare, ingestibles, and wellness products, with rising consumer demand for holistic, bioactive solutions. Synbiotics also enable precision microbiome modulation, fostering regulatory confidence and scientific validation. As a result, they're reshaping product development pipelines and accelerating adoption across beauty, nutraceutical, and therapeutic verticals.

The serums segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the serums segment is predicted to witness the highest growth rate, due to rising consumer demand for minimalist, high-efficacy formulations, serums offer an ideal format for incorporating microbiome-balancing ingredients like postbiotics and fermented extracts. Their lightweight, targeted nature enhances ingredient bioavailability, driving innovation in active encapsulation and synergistic blends. This convergence is fostering premiumization, expanding dermocosmetic applications, and positioning microbiome-friendly actives as essential pillars of next-gen skin health.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising consumer demand for holistic wellness and scientifically backed formulations. With growing awareness of gut-skin-brain connections, brands are innovating across food, personal care, and supplements to support microbial balance. Japan and Southeast Asia lead adoption, fueled by aging populations and proactive health strategies. Regulatory shifts and regional R&D investments further accelerate growth, positioning microbiome-friendly actives as a transformative force in preventive healthcare and consumer trust.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising consumer awareness of gut-skin health connection, demand for natural and clean-label products, and a thriving personalized skincare industry. The region's advanced R&D ecosystem, presence of leading cosmetic and nutraceutical brands, and strong regulatory emphasis on safety and efficacy further accelerate market adoption. Growing investments in biotech innovations and consumer preference for probiotic and prebiotic-based actives reinforce steady growth momentum.

Key players in the market

Some of the key players profiled in the Microbiome-Friendly Actives Market include Chr. Hansen Holding A/S, DuPont, Lonza Group AG, Yakult Honsha Co., Ltd., Lesaffre Group, Nestle Health Science, Danone S.A., Evonik Industries AG, BioGaia AB, DSM-Firmenich AG, Probi AB, SynbioTech Inc., Kerry Group plc, Novozymes A/S, Herbalife Nutrition Ltd., Arla Foods Ingredients Group, Sabinsa Corporation and Morinaga Milk Industry Co., Ltd.

Key Developments:

In June 2025, Nestle has embarked on collaborations in New Zealand and the UK to explore integrated multi-trophic aquaculture, where seaweed and shellfish mutually nourish one another. This approach promises a graceful, sustainable symbiosis-boosting biodiversity, water quality, and ecosystem restoration.

In May 2025, DuPont and Epicore Biosystems have partnered to fuse DuPont's protective garment expertise with Epicore's sweat-sensing Connected Hydration wearables, aiming to deliver real-time biometrics and personalized hydration insights to enhance worker safety in heat-stress environments.

In June 2025, Ethris has partnered with Lonza to develop room-temperature-stable, spray-dried mRNA vaccine formulations for mucosal delivery via nasal administration, beginning with an influenza candidate. This method promises to simplify cold-chain logistics and enhance accessibility for respiratory disease prevention.

Ingredient Types Covered:

  • Prebiotics
  • Probiotics
  • Postbiotics
  • Synbiotics
  • Botanical Extracts
  • Peptides
  • Vitamins & Minerals

Forms Covered:

  • Capsules & Tablets
  • Powders
  • Liquids
  • Gummies
  • Creams & Lotions
  • Serums
  • Oils

Technologies Covered:

  • Genomics-based Actives
  • Metabolomics-derived Compounds
  • AI-personalized Microbiome Formulations
  • Encapsulation & Delivery Systems

Distribution Channels Covered:

  • Hypermarkets/Supermarkets
  • Specialty Stores
  • Pharmacies
  • Online Retail
  • Dermatology Clinics

Applications Covered:

  • Skin Care
  • Hair Care
  • Oral Care
  • Feminine Hygiene
  • Baby Care
  • Wound Healing
  • Anti-aging & Barrier Repair

End Users Covered:

  • Adults
  • Children
  • Geriatric Population
  • Pets & Livestock

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbiome-Friendly Actives Market, By Ingredient Type

  • 5.1 Introduction
  • 5.2 Prebiotics
  • 5.3 Probiotics
  • 5.4 Postbiotics
  • 5.5 Synbiotics
  • 5.6 Botanical Extracts
  • 5.7 Peptides
  • 5.8 Vitamins & Minerals

6 Global Microbiome-Friendly Actives Market, By Form

  • 6.1 Introduction
  • 6.2 Capsules & Tablets
  • 6.3 Powders
  • 6.4 Liquids
  • 6.5 Gummies
  • 6.6 Creams & Lotions
  • 6.7 Serums
  • 6.8 Oils

7 Global Microbiome-Friendly Actives Market, By Technology

  • 7.1 Introduction
  • 7.2 Genomics-based Actives
  • 7.3 Metabolomics-derived Compounds
  • 7.4 AI-personalized Microbiome Formulations
  • 7.5 Encapsulation & Delivery Systems

8 Global Microbiome-Friendly Actives Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hypermarkets/Supermarkets
  • 8.3 Specialty Stores
  • 8.4 Pharmacies
  • 8.5 Online Retail
  • 8.6 Dermatology Clinics

9 Global Microbiome-Friendly Actives Market, By Application

  • 9.1 Introduction
  • 9.2 Skin Care
  • 9.3 Hair Care
  • 9.4 Oral Care
  • 9.5 Feminine Hygiene
  • 9.6 Baby Care
  • 9.7 Wound Healing
  • 9.8 Anti-aging & Barrier Repair

10 Global Microbiome-Friendly Actives Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Children
  • 10.4 Geriatric Population
  • 10.5 Pets & Livestock

11 Global Microbiome-Friendly Actives Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Chr. Hansen Holding A/S
  • 13.2 DuPont
  • 13.3 Lonza Group AG
  • 13.4 Yakult Honsha Co., Ltd.
  • 13.5 Lesaffre Group
  • 13.6 Nestle Health Science
  • 13.7 Danone S.A.
  • 13.8 Evonik Industries AG
  • 13.9 BioGaia AB
  • 13.10 DSM-Firmenich AG
  • 13.11 Probi AB
  • 13.12 SynbioTech Inc.
  • 13.13 Kerry Group plc
  • 13.14 Novozymes A/S
  • 13.15 Herbalife Nutrition Ltd.
  • 13.16 Arla Foods Ingredients Group
  • 13.17 Sabinsa Corporation
  • 13.18 Morinaga Milk Industry Co., Ltd.

List of Tables

  • Table 1 Global Microbiome-Friendly Actives Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Microbiome-Friendly Actives Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 3 Global Microbiome-Friendly Actives Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 4 Global Microbiome-Friendly Actives Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 5 Global Microbiome-Friendly Actives Market Outlook, By Postbiotics (2024-2032) ($MN)
  • Table 6 Global Microbiome-Friendly Actives Market Outlook, By Synbiotics (2024-2032) ($MN)
  • Table 7 Global Microbiome-Friendly Actives Market Outlook, By Botanical Extracts (2024-2032) ($MN)
  • Table 8 Global Microbiome-Friendly Actives Market Outlook, By Peptides (2024-2032) ($MN)
  • Table 9 Global Microbiome-Friendly Actives Market Outlook, By Vitamins & Minerals (2024-2032) ($MN)
  • Table 10 Global Microbiome-Friendly Actives Market Outlook, By Form (2024-2032) ($MN)
  • Table 11 Global Microbiome-Friendly Actives Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
  • Table 12 Global Microbiome-Friendly Actives Market Outlook, By Powders (2024-2032) ($MN)
  • Table 13 Global Microbiome-Friendly Actives Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 14 Global Microbiome-Friendly Actives Market Outlook, By Gummies (2024-2032) ($MN)
  • Table 15 Global Microbiome-Friendly Actives Market Outlook, By Creams & Lotions (2024-2032) ($MN)
  • Table 16 Global Microbiome-Friendly Actives Market Outlook, By Serums (2024-2032) ($MN)
  • Table 17 Global Microbiome-Friendly Actives Market Outlook, By Oils (2024-2032) ($MN)
  • Table 18 Global Microbiome-Friendly Actives Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global Microbiome-Friendly Actives Market Outlook, By Genomics-based Actives (2024-2032) ($MN)
  • Table 20 Global Microbiome-Friendly Actives Market Outlook, By Metabolomics-derived Compounds (2024-2032) ($MN)
  • Table 21 Global Microbiome-Friendly Actives Market Outlook, By AI-personalized Microbiome Formulations (2024-2032) ($MN)
  • Table 22 Global Microbiome-Friendly Actives Market Outlook, By Encapsulation & Delivery Systems (2024-2032) ($MN)
  • Table 23 Global Microbiome-Friendly Actives Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 24 Global Microbiome-Friendly Actives Market Outlook, By Hypermarkets/Supermarkets (2024-2032) ($MN)
  • Table 25 Global Microbiome-Friendly Actives Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 26 Global Microbiome-Friendly Actives Market Outlook, By Pharmacies (2024-2032) ($MN)
  • Table 27 Global Microbiome-Friendly Actives Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 28 Global Microbiome-Friendly Actives Market Outlook, By Dermatology Clinics (2024-2032) ($MN)
  • Table 29 Global Microbiome-Friendly Actives Market Outlook, By Application (2024-2032) ($MN)
  • Table 30 Global Microbiome-Friendly Actives Market Outlook, By Skin Care (2024-2032) ($MN)
  • Table 31 Global Microbiome-Friendly Actives Market Outlook, By Hair Care (2024-2032) ($MN)
  • Table 32 Global Microbiome-Friendly Actives Market Outlook, By Oral Care (2024-2032) ($MN)
  • Table 33 Global Microbiome-Friendly Actives Market Outlook, By Feminine Hygiene (2024-2032) ($MN)
  • Table 34 Global Microbiome-Friendly Actives Market Outlook, By Baby Care (2024-2032) ($MN)
  • Table 35 Global Microbiome-Friendly Actives Market Outlook, By Wound Healing (2024-2032) ($MN)
  • Table 36 Global Microbiome-Friendly Actives Market Outlook, By Anti-aging & Barrier Repair (2024-2032) ($MN)
  • Table 37 Global Microbiome-Friendly Actives Market Outlook, By End User (2024-2032) ($MN)
  • Table 38 Global Microbiome-Friendly Actives Market Outlook, By Adults (2024-2032) ($MN)
  • Table 39 Global Microbiome-Friendly Actives Market Outlook, By Children (2024-2032) ($MN)
  • Table 40 Global Microbiome-Friendly Actives Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 41 Global Microbiome-Friendly Actives Market Outlook, By Pets & Livestock (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.